AKT1 and cancer: PIK3CA was the second most commonly mutated gene (9%) next to TP53[65]; and PI3K/AKT/mTOR pathway in basal-like cancers can be activated through PIK3CA or AKT1 activating mutations and/or PTEN loss[65,66].